Pancreatic Cancer Research

Journal articleMol Med Rep2024

IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.

Journal
Mol Med Rep
Published
15 March 2024
Citations
5
Type
Article
License
cc by-nc-nd

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc-nd

Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent and aggressive form of pancreatic cancer. Gemcitabine (GEM), the first‑line treatment for PDAC, which alleviates symptoms and enhances the quality of life of patients. … Excerpt only: this text is the publisher’s. Read it in full at the source.